RxDoctor Payments Data

Ahmad Ahmad, MD

Internal Medicine · Detroit, MINPI 1992048607

Payments from drug & device makers

$668in general payments, 2019–2025

Across 25 payments — averaging $26.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$134
  • Pfizer$102
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$97
  • Merck$67
  • Cardiovascular Systems Inc.$50
  • Boehringer Ingelheim$49
  • plus $171 from 7 others

What the payments were for

  • Food & beverage$668100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$668 in reported general payments places this provider in the 70th percentile of 4,567 internal medicine providers in Michigan.

See all internal medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$589,894
Medicare patients
1,011
Services billed
5,912

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban394$120,024
NuedextaDextromethorphan Hbr/Quinidine33$25,993
XareltoRivaroxaban77$23,917
EntrestoSacubitril/Valsartan73$21,178
JardianceEmpagliflozin48$16,190
JanuviaSitagliptin Phosphate44$14,743
FarxigaDapagliflozin Propanediol40$14,573
MyrbetriqMirabegron53$11,634
Atorvastatin Calcium534$8,397
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$7,460
Fluticasone-SalmeterolFluticasone Propion/Salmeterol35$5,450
Midodrine Hcl89$4,871
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen291$4,862
Pantoprazole Sodium228$4,614
Gabapentin319$4,258

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$102$120,024394 claims
Johnson & JohnsonXarelto$134$23,91777 claims
AstraZenecaFarxiga, Brilinta$31$18,34953 claims
Boehringer IngelheimJardiance$49$16,19048 claims
MerckJanuvia$67$14,74344 claims
AbbVieCreon$38$2,50015 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,567 internal medicine providers in Michigan.

Other internal medicine in Detroit

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →